Consequential drug combinations for tuberculosis treatments.
Publication
, Journal Article
Pyle, CJ; Tobin, DM
Published in: Cell Syst
November 17, 2021
Improved therapies for tuberculosis will require the careful revision of complex, multi-drug regimens. In this issue of Cell Systems, Larkins-Ford et al. integrate extensive dose-response measurements of drug combinations, in vivo animal data, and computational analysis to provide a new predictive framework for the prioritization of specific antitubercular drug regimens.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cell Syst
DOI
EISSN
2405-4720
Publication Date
November 17, 2021
Volume
12
Issue
11
Start / End Page
1021 / 1022
Location
United States
Related Subject Headings
- Tuberculosis
- Drug Combinations
- Antitubercular Agents
- Animals
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pyle, C. J., & Tobin, D. M. (2021). Consequential drug combinations for tuberculosis treatments. Cell Syst, 12(11), 1021–1022. https://doi.org/10.1016/j.cels.2021.10.005
Pyle, Charlie J., and David M. Tobin. “Consequential drug combinations for tuberculosis treatments.” Cell Syst 12, no. 11 (November 17, 2021): 1021–22. https://doi.org/10.1016/j.cels.2021.10.005.
Pyle CJ, Tobin DM. Consequential drug combinations for tuberculosis treatments. Cell Syst. 2021 Nov 17;12(11):1021–2.
Pyle, Charlie J., and David M. Tobin. “Consequential drug combinations for tuberculosis treatments.” Cell Syst, vol. 12, no. 11, Nov. 2021, pp. 1021–22. Pubmed, doi:10.1016/j.cels.2021.10.005.
Pyle CJ, Tobin DM. Consequential drug combinations for tuberculosis treatments. Cell Syst. 2021 Nov 17;12(11):1021–1022.
Published In
Cell Syst
DOI
EISSN
2405-4720
Publication Date
November 17, 2021
Volume
12
Issue
11
Start / End Page
1021 / 1022
Location
United States
Related Subject Headings
- Tuberculosis
- Drug Combinations
- Antitubercular Agents
- Animals
- 0601 Biochemistry and Cell Biology